11/14/2024
3:33 PM | ArriVent BioPharma (Subject)
HHLR ADVISORS, LTD. (Filed by)
| Form SC 13G | |
11/14/2024
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:01 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
1:45 PM | ArriVent BioPharma (Subject)
Sofinnova Venture Partners XI, L.P. (Filed by)
| Form SC 13G | |
10/24/2024
1:02 PM | ArriVent BioPharma (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
09/23/2024
5:14 PM | ArriVent BioPharma (Issuer)
LaChapelle Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
11:15 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
07/09/2024
4:03 PM | ArriVent BioPharma (Filer)
| Form 8-K/A | |
07/09/2024
4:05 PM | ArriVent BioPharma (Filer)
| Form 8-K/A | |
06/05/2024
6:15 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
4:29 PM | ArriVent BioPharma (Issuer)
Hohneker John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/20/2024
4:30 PM | ArriVent BioPharma (Issuer)
Hohneker John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
7:00 AM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:01 AM | ArriVent BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2024
3:05 PM | ArriVent BioPharma (Issuer)
Peterson Kristine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/23/2024
3:06 PM | ArriVent BioPharma (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:10 PM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
3:42 PM | ArriVent BioPharma (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D | |
02/01/2024
3:47 PM | ArriVent BioPharma (Issuer)
HHLR ADVISORS, LTD. (Reporting)
HILLHOUSE INVESTMENT MANAGEMENT, LTD. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:10 PM | ArriVent BioPharma (Issuer)
HEALY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:11 PM | ArriVent BioPharma (Issuer)
GORDON CARL L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:12 PM | ArriVent BioPharma (Issuer)
OrbiMed Advisors IV Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Asia GP IV, L.P. (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:05 PM | ArriVent BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
11:15 PM | ArriVent BioPharma (Filer)
| Form EFFECT | |
01/25/2024
8:01 PM | ArriVent BioPharma (Issuer)
HILLHOUSE INVESTMENT MANAGEMENT, LTD. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:36 PM | ArriVent BioPharma (Issuer)
Jallal Bahija (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:36 PM | ArriVent BioPharma (Issuer)
GORDON CARL L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:37 PM | ArriVent BioPharma (Issuer)
HEALY JAMES (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:38 PM | ArriVent BioPharma (Issuer)
Kastenmayer James Paul (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:38 PM | ArriVent BioPharma (Issuer)
Kung Winston (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:38 PM | ArriVent BioPharma (Issuer)
LaChapelle Robin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:39 PM | ArriVent BioPharma (Issuer)
Lutzker Stuart (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:39 PM | ArriVent BioPharma (Issuer)
Nolet Chris (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:39 PM | ArriVent BioPharma (Issuer)
Yao Zhengbin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
7:40 PM | ArriVent BioPharma (Issuer)
OrbiMed Advisors IV Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Asia GP IV, L.P. (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/25/2024
6:37 PM | ArriVent BioPharma (Filer)
| Form S-1MEF | |
01/25/2024
11:32 AM | ArriVent BioPharma (Filer)
| Form CERT | |
01/23/2024
4:18 PM | ArriVent BioPharma (Filer)
| Form S-1/A | |
01/23/2024
3:08 PM | ArriVent BioPharma (Filer)
| Form 8-A12B | |
01/22/2024
5:35 AM | ArriVent BioPharma (Filer)
| Form S-1/A | |
01/05/2024
3:16 PM | ArriVent BioPharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
I've got news for you… (Ad) Today, I’m doing something I thought I’d never do…
Especially since I’m not normally a “swing for the fences” type of trader.
But I’ve been quietly testing a new type of trade for a while now…
And the returns are too good not to share with you.
Take a look…
I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week watch this FREE briefing with me and expert trader Graham Lindman |
Free AVBP Stock Alerts